A Prospective, Multi-Center, Observational Study to Evaluate the Efficacy of OLMETEC Tab. (or OLMETEC Plus Tab.) on Nocturnal Blood Pressure Control in Korean Patients With Stage Ⅰ Hypertension
This is a prospective, multicenter, observational study to evaluate the effectiveness of Olmetec® or Olmetec Plus® on nocturnal blood pressure control in Korean patients with stage 1 hypertension. Patients receiving Olmetec-based therapy in routine clinical practice will be followed to assess changes in ambulatory blood pressure, including nocturnal blood pressure and blood pressure variability.
• Adults aged ≥19 years
• Patients diagnosed with stage 1 hypertension according to clinical guidelines
• Patients who are newly prescribed Olmetec® or Olmetec Plus® in routine -clinical practice
• Patients who are able to undergo ambulatory blood pressure monitoring (ABPM)
• Patients who voluntarily agree to participate and provide written informed consent